Atlas

FDA-Inspected Site

Noramco, Inc.

10 FDA inspections are on record for Noramco, Inc. in Wilmington, United States.

483· Form 483 issued

Wilmington, United States · Last updated July 10, 2026

Overview

  • 10 FDA inspections are on record.
  • 2 inspections produced a Form 483.
  • The most recent recorded inspection date is 2025-10-15.

At a glance

Inspections

10

Form 483s

2

EIRs

1

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
7 Oct 2025 – 15 Oct 2025Human Drugs483On file
14 Nov 2022 – 18 Nov 2022Human DrugsClean
19 Feb 2019 – 21 Feb 2019Human DrugsClean
13 Nov 2017 – 17 Nov 2017Human DrugsClean
20 Jan 2016 – 21 Jan 2016Human DrugsClean
10 Nov 2014 – 13 Nov 2014Human DrugsClean
27 Apr 2012Not recordedClean
2 Aug 2010Not recorded483On file
2 May 2008Not recordedClean
8 May 2001Not recordedClean

Investigators

FDA investigators tied to this site in the record.

Anita R Michael4 insp.
Michael A Taylor2 insp.
Junho Pak1 insp.
Michael L Casner1 insp.
Djamila Harouaka1 insp.
Thomas E Friel1 insp.

Full site report

Get the verbatim findings behind Noramco, Inc.'s 2 Form 483s

The full inspection record, as Atlas holds it, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat